| Ticker Details |
|
GeoVax Labs, Inc.
|
| IPO Date: |
September 25, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$2.58M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 5.14%
|
| Avg Daily Range (30 D): |
$0.06 | 3.95%
|
| Avg Daily Range (90 D): |
$0.08 | 5.66%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.04M |
| Avg Daily Volume (30 D): |
.05M |
| Avg Daily Volume (90 D): |
.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
5 |
| Avg Trade Size (Sh.) (30 D): |
141 |
| Avg Trade Size (Sh.) (90 D): |
49 |
| Institutional Trades |
| Total Institutional Trades: |
13 |
| Avg Institutional Trade: |
$.99M |
| Avg Institutional Trade (30 D): |
$.57M |
| Avg Institutional Trade (90 D): |
$.57M |
| Avg Institutional Trade Volume: |
M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.29M |
| Avg Closing Trade (30 D): |
$1.29M |
| Avg Closing Trade (90 D): |
$1.29M |
| Avg Closing Volume: |
6.19K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.27
|
$-.31
|
$-.35
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$3.35M
|
$M
|
$.85M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-25.31M
|
$-6.32M
|
$-5.37M
|
|
Operating Income / Loss
|
$-25.54M
|
$-6.37M
|
$-5.42M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-3.58M
|
$1.92M
|
$-4.34M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jan 12, 2026
|
1:25
|
|
Jan 31, 2024
|
1:15
|
|
Sep 25, 2020
|
1:20
|
|
Jan 24, 2020
|
1:2000
|
|
May 02, 2019
|
1:500
|
|
Apr 28, 2010
|
1:50
|
|
|
|